We are here to help.
Learn more about the Depo-Provera Birth Control Injection Brain Tumor Class Action
or call 1 (866) 308-7722 for a free consultation.
What is Depo-Provera?
Launched in 1992, Depo-Provera by Pfizer Inc. has gained popularity as an effective and convenient birth control injection containing medroxyprogesterone, a synthetic progesterone. Administered intramuscularly every three months, it offers a long-lasting, reversible contraceptive solution for many women. Besides birth control, Depo-Provera also treats endometriosis, injected into the muscle of the upper arm or buttocks quarterly. It suppresses ovulation with a high dose of progestin. At 150 mg/mL, it's considered one of the most effective contraceptives, on par with sterilization, minimizing unintended pregnancies.
What Are the Potential Risks?
Studies suggest Depo-Provera and depo-subQ provera 104 may increase the risk of intracranial meningiomas, tumors that grow in the protective layers around the brain and the spinal cord. While these tumors are typically benign, their growth can lead to significant health issues, depending on their location and size.
Who is Included?
Related FAQs
What is the deadline for filing a lawsuit related to Depo-Provera?
Lawsuits for drug-related injuries, like those involving Depo-Provera, are subject to statutes of limitations, which may differ by province. The countdown typically begins when you are diagnosed with a tumour or when the condition can reasonably be linked to Depo-Provera.
To protect your rights, consult a lawyer as soon as possible to determine your specific timeline.
- Class Action
- Gluckstein main site